Literature DB >> 12135934

Beta-blockers in the post-myocardial infarction patient.

Mihai Gheorghiade1, Sidney Goldstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135934     DOI: 10.1161/01.cir.0000019582.39797.ef

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  11 in total

Review 1.  Optimising the use of beta-adrenoceptor antagonists in coronary artery disease.

Authors:  Kristin E Ellison; Gaurang Gandhi
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Impact of heart disease and quality of care on minority populations in the United States.

Authors:  Garth N Graham; Mayadallia Guendelman; Benjamin S Leong; Sara Hogan; Adrienne Dennison
Journal:  J Natl Med Assoc       Date:  2006-10       Impact factor: 1.798

Review 3.  Infarct restraint to limit adverse ventricular remodeling.

Authors:  Robert C Gorman; Benjamin M Jackson; Jason A Burdick; Joseph H Gorman
Journal:  J Cardiovasc Transl Res       Date:  2010-12-15       Impact factor: 4.132

Review 4.  Matrix Metalloproteinases in Myocardial Infarction and Heart Failure.

Authors:  Kristine Y DeLeon-Pennell; Cesar A Meschiari; Mira Jung; Merry L Lindsey
Journal:  Prog Mol Biol Transl Sci       Date:  2017-03-18       Impact factor: 3.622

Review 5.  Beta blocker therapy after acute myocardial infarction in patients with heart failure and systolic dysfunction.

Authors:  Emil Thattassery; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2004-04       Impact factor: 4.214

6.  Relation of patient age and mortality to reported contraindications to early beta-blocker use for non-ST-elevation acute coronary syndrome.

Authors:  Nancy M Allen LaPointe; Anita Y Chen; Matthew T Roe; David J Cohen; Deborah B Diercks; James W Hoekstra; Francis M Fesmire; W Brian Gibler; E Magnus Ohman; Eric D Peterson
Journal:  Am J Cardiol       Date:  2009-09-26       Impact factor: 2.778

7.  Hypertension and end-organ disease in African Americans: case presentations.

Authors:  Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-04       Impact factor: 3.738

8.  Beta-blocker therapy in patients with left ventricular systolic dysfunction and chronic obstructive lung disease in an ambulatory care setting.

Authors:  Jennifer J Schimmer; Sarah J Billups; Thomas Delate
Journal:  Pharm Pract (Granada)       Date:  2009-03-15

9.  Effect of Beta Blockers and Renin-Angiotensin System Inhibitors on Survival in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.

Authors:  Pil Hyung Lee; Gyung-Min Park; Young-Hak Kim; Sung-Cheol Yun; Mineok Chang; Jae-Hyung Roh; Sung-Han Yoon; Jung-Min Ahn; Duk-Woo Park; Soo-Jin Kang; Seung-Whan Lee; Cheol Whan Lee; Seong-Wook Park; Seung-Jung Park
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 10.  Realities of newer beta-blockers for the management of hypertension.

Authors:  Camila Manrique; Thomas D Giles; Keith C Ferdinand; James R Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-07       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.